Dmitry Balyasny’s Legend Biotech LEGN Stock Holding History

Dmitry Balyasny’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.09M	Buy	+210,996	New	+$5.69M	0.01%	1288
2026 Q1	–	Sell	-343,785	Closed	-$7.47M	–	3229
2025 Q4	$7.47M	Buy	343,785 +308,618	+878%	+$8.84M	0.01%	1176
2025 Q3	$1.15M	Sell	35,167 -912,466	-96%	-$33.7M	﹤0.01%	2058
2025 Q2	$33.6M	Buy	947,633 +746,642	+371%	+$24.2M	0.05%	456
2025 Q1	$6.82M	Sell	200,991 -898,534	-82%	-$32.2M	0.01%	1110
2024 Q4	$35.8M	Buy	1,099,525 +418,351	+61%	+$17.3M	0.05%	436
2024 Q3	$33.2M	Buy	681,174 +229,209	+51%	+$12.2M	0.05%	441
2024 Q2	$20M	Buy	+451,965	New	+$20.8M	0.04%	606
2022 Q4	–	Sell	-16,000	Closed	-$653K	–	3022
2022 Q3	$653K	Buy	16,000 +10,485	+190%	+$492K	﹤0.01%	1958
2022 Q2	$303K	Buy	+5,515	New	+$233K	﹤0.01%	2099

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Dmitry Balyasny's LEGN Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Legend Biotech (LEGN) in Q2 2026: 210,996 shares worth $6.09M. The stake represents 0.01% of the portfolio and ranks #1288 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in LEGN as recently as Q4 2025.

Dmitry Balyasny first reported a position in LEGN in Q2 2022 and has held it in 10 quarters since. The position peaked at $35.8M in Q4 2024. 217 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Dmitry Balyasny held 210,996 shares of Legend Biotech worth $6.09M as of Q2 2026.
Legend Biotech was a new Dmitry Balyasny position in Q2 2026.
Legend Biotech made up 0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1288 holding.
Dmitry Balyasny first reported a position in Legend Biotech in Q2 2022 and has held it in 10 quarters since.
Dmitry Balyasny's Legend Biotech position peaked at $35.8M in Q4 2024.
217 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.